AC Immune (ACIU) has disclosed that its partner Janssen Pharmaceuticals of Johnson & Johnson (JNJ) has temporarily paused enrollments in a mid-stage trial for their jointly developed Alzheimer’s ...

Janssen, Johnson & Johnson’s pharmaceutical arm, launched a nine-month digital health startup accelerator focusing on predictive diagnostic models and treatment management devices. The initiative, ...

Stelara (ustekinumab) is indicated for moderate to severe psoriasis, active psoriatic arthritis, Crohn's disease, and ulcerative colitis. Janssen had previously reached agreements allowing competitors ...

A better understanding of early childhood microbiome shifts offers a unique window for detecting disease risk and intervening appropriately. In this webinar, Lloyd Bod and Nathaniel Robichaud will ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...